News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
Key Takeaways Moderna said the FDA approved its new COVID-19 vaccine "for use in all adults 65 and older, as well as ...
The rewriting of government recommendations will make the effort to get vaccine doses into arms exponentially more difficult, ...
Moderna’s newest lower-dose COVID-19 vaccine is approved for all adults 65 and older, and for people aged 12 to 64 who are at ...
3don MSN
FDA Commissioner Marty Makary defended the U.S. federal health agencies recent removal of the COVID-19 vaccine from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback